<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties manuscript?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-journal-id">101518086</journal-id><journal-id journal-id-type="pubmed-jr-id">37048</journal-id><journal-id journal-id-type="nlm-ta">Arthritis Care Res (Hoboken)</journal-id><journal-id journal-id-type="iso-abbrev">Arthritis Care Res (Hoboken)</journal-id><journal-title-group><journal-title>Arthritis care &#x00026; research</journal-title></journal-title-group><issn pub-type="ppub">2151-464X</issn><issn pub-type="epub">2151-4658</issn></journal-meta><article-meta><article-id pub-id-type="pmid">39400995</article-id><article-id pub-id-type="pmc">11932797</article-id><article-id pub-id-type="doi">10.1002/acr.25446</article-id><article-id pub-id-type="manuscript">NIHMS2028525</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Limitations in Activities of Daily Living among Individuals with Systemic Lupus Erythematosus</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Plantinga</surname><given-names>Laura C.</given-names></name><degrees>PhD</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Bowling</surname><given-names>C. Barrett</given-names></name><degrees>MD, MSPH</degrees><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Pearce</surname><given-names>Bradley D.</given-names></name><degrees>PhD</degrees><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Hoge</surname><given-names>Courtney</given-names></name><degrees>MSPH</degrees><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Dunlop-Thomas</surname><given-names>Charmayne</given-names></name><degrees>MS, MPH</degrees><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Lim</surname><given-names>S. Sam</given-names></name><degrees>MD, MPH</degrees><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Katz</surname><given-names>Patricia P.</given-names></name><degrees>PhD</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Yazdany</surname><given-names>Jinoos</given-names></name><degrees>MD, MPH</degrees><xref rid="A1" ref-type="aff">1</xref></contrib></contrib-group><aff id="A1"><label>1</label>University of California, San Francisco, San Francisco, California;</aff><aff id="A2"><label>2</label>Durham Veterans Affairs Medical Center and Duke University, Durham, North Carolina;</aff><aff id="A3"><label>3</label>Emory University, Atlanta, Georgia</aff><author-notes><corresp id="CR1"><bold>Correspondence to:</bold> Laura C. Plantinga, 2540 23<sup>rd</sup> Street, Pride Hall Room 4403, San Francisco, CA 94110. <email>laura.plantinga@ucsf.edu</email>.</corresp></author-notes><pub-date pub-type="nihms-submitted"><day>12</day><month>10</month><year>2024</year></pub-date><pub-date pub-type="ppub"><month>4</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>10</day><month>11</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>01</day><month>4</month><year>2026</year></pub-date><volume>77</volume><issue>4</issue><fpage>440</fpage><lpage>450</lpage><abstract id="ABS1"><sec id="S1"><title>Objective:</title><p id="P1">We aimed to estimate the burden and identify potential correlates of limitations in activities of daily living (ADLs) among persons with systemic lupus erythematosus (SLE).</p></sec><sec id="S2"><title>Methods:</title><p id="P2">Individuals with SLE were recruited from a population-based cohort (10/2019&#x02013;5/2022) and reported their ability to independently perform various instrumental ADLs (IADLs) and basic ADLs (BADLs) via survey. Limitations were defined as having at least some difficulty performing at least one of the IADLs or BADLs. Descriptive statistics were calculated, and associations [adjusted odds ratios (aORs)] of various participant characteristics with IADL and BADL limitations were assessed with logistic regression adjusting for age, sex, and race.</p></sec><sec id="S3"><title>Results:</title><p id="P3">The mean age of the 436 participants was 46.2 years; most were female (91.7%) and Black (82.8%). More than half (56.2%) reported limitations in IADLs, most commonly housekeeping (50.7%), laundry (37.2%), and shopping (33.0%); 43.8% reported limitations in independently performing BADLs, most commonly transferring (26.6%), bathing (25.3%), dressing (24.4%), and continence (22.0%). Higher disease activity (&#x02265; vs. &#x0003c;median) was most strongly associated with IADLs (aOR=6.49, 95% CI 4.15&#x02013;10.2) and BADLs (aOR=7.35, 95% CI 4.70&#x02013;11.5), along with higher depression and perceived stress scores; lower educational attainment and income; and older age.</p></sec><sec id="S4"><title>Conclusion:</title><p id="P4">IADL and BADL limitations may be common in SLE and more prevalent among those who report higher disease activity, depressive symptoms, and lower income and among those who are older. Research to support evidence-based strategies for improvement in quality of life and maintenance of independence in the aging SLE population is warranted.</p></sec></abstract><abstract id="ABS2" abstract-type="graphical"><title>Graphical Abstract</title><p id="P114">
<graphic xlink:href="nihms-2028525-f0004.jpg" position="anchor"/>
</p></abstract></article-meta></front><body><sec id="S5"><title>Introduction</title><p id="P5">With increasing life expectancy among those with systemic lupus erythematosus (SLE),<sup><xref rid="R1" ref-type="bibr">1</xref></sup> a primary goal of SLE providers should be maintaining patient independence among their patients as they age. To address this, we first need to understand the current state of limitations in the essential, routine tasks known as activities of daily living (ADLs) among an aging population with SLE and the factors associated with these limitations. ADLs include instrumental ADLs (IADLs), which meet personal needs for independent community living (<italic toggle="yes">e.g</italic>., food preparation and household chores),<sup><xref rid="R2" ref-type="bibr">2</xref></sup> and basic ADLs (BADLs), which meet basic personal physical needs (<italic toggle="yes">e.g</italic>., bathing and dressing)<sup><xref rid="R3" ref-type="bibr">3</xref></sup>; limitations in either can lead to poor quality of life and loss of independence.</p><p id="P6">ADL limitations are most frequently associated with older populations. However, in 2019, 6% of U.S. adults aged 18&#x02013;64 years reported a lot of difficulty or inability to perform in at least one functional domain, and these limitations were more common among those who were Black (7%) or living below the poverty level (15%).<sup><xref rid="R4" ref-type="bibr">4</xref></sup> Further, for those with chronic conditions, such as arthritis, the prevalence of ADL limitations can be much higher, regardless of age.<sup><xref rid="R5" ref-type="bibr">5</xref></sup> Given that the population with SLE is disproportionately underserved and socioeconomically disadvantaged &#x02014; and that SLE is a complex, chronic, and heterogeneous disease &#x02014; understanding the prevalence of and factors associated with IADL and BADL limitations in these patients is even more important for maximizing independence and minimizing disability.</p><p id="P7">While there is some evidence suggesting that ADL limitations may be highly prevalent in SLE,<sup><xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R7" ref-type="bibr">7</xref></sup> less is known about the specific measures of IADLs and BADLs in SLE. To address this gap, we sought to characterize the burden and correlates of limitations in IADLs and BADLs in a population-based cohort of individuals with SLE.</p></sec><sec id="S6"><title>Methods</title><sec id="S7"><title>Study Population and Data Sources</title><p id="P8">The Approaches to Positive, Patient-centered Experiences of Aging with Lupus (APPEAL) study recruited participants with validated SLE<sup><xref rid="R8" ref-type="bibr">8</xref></sup> from the population-based Georgians Organized Against Lupus (GOAL) cohort in metropolitan Atlanta,<sup><xref rid="R9" ref-type="bibr">9</xref>,<xref rid="R10" ref-type="bibr">10</xref></sup> with exclusions for being inactive in GOAL, being unable to speak English, having insufficient vision and hearing to undergo study testing, being unable to consent, or living outside of Georgia at the time of recruitment. The Emory Institutional Review Board approved the APPEAL (IRB00110977) and GOAL (IRB00003656) study protocols. APPEAL participants provided informed consent before completing study visits.</p><p id="P9">A total of 451 participants completed the APPEAL study visit between 10/8/2019 and 5/12/2022. For this analysis, we excluded participants whose overall survey response patterns were potentially invalid (<italic toggle="yes">n</italic>=4) or who did not have complete IADL and BADL assessments (<italic toggle="yes">n</italic>=11). Study data were obtained from performance tests and self-administered questionnaires and additionally linked to data from the GOAL survey closest to the APPEAL visit date.</p></sec><sec id="S8"><title>Variables</title><sec id="S9"><title>Limitations in ADLs.</title><p id="P10">Participants were asked about their limitations in the following IADLs<sup><xref rid="R2" ref-type="bibr">2</xref></sup>: using the phone, shopping, food preparation, housekeeping, laundry, transportation, managing medications, and managing finances (<xref rid="T1" ref-type="table">Table 1</xref>). BADLs<sup><xref rid="R3" ref-type="bibr">3</xref></sup> assessed included bathing, dressing, toileting, transferring, feeding, and continence (<xref rid="T1" ref-type="table">Table 1</xref>). For primary analyses, IADL and BADL limitations were defined as any difficulty (some or more difficulty) vs. no difficulty performing at least one of the IADL and BADL tasks independently.</p></sec><sec id="S10"><title>Other variables.</title><p id="P11">Sociodemographics included age, sex (at birth), race, ethnicity, and education, all self-reported by the participant via the NIH Toolbox from a fixed set of categories. Race was categorized as Black (single or multiple race), other, and White. Education was the highest level attained and categorized as high school graduate/equivalency or lower, some college/associates degree, and college graduate or higher. Current working status was assessed with the Work Productivity and Activity Impairment Questionnaire.<sup><xref rid="R11" ref-type="bibr">11</xref>&#x02013;<xref rid="R13" ref-type="bibr">13</xref></sup> Current income (categorized as &#x0003c;$20,000, $20,000&#x02013;59,999, and &#x02265;$60,000), receipt of Social Security disability benefits, and disease duration (adjusted for the date of the APPEAL visit) were self-reported at the closest GOAL assessment. Current SLE activity was assessed via the Systematic Lupus Activity Questionnaire (SLAQ; range 0&#x02013;44; higher scores indicating greater SLE-related disease activity).<sup><xref rid="R14" ref-type="bibr">14</xref></sup> The Brief Index of Lupus Damage (BILD) score (range, 0&#x02013;46; higher scores indicate greater cumulative SLE-related organ damage)<sup><xref rid="R15" ref-type="bibr">15</xref>,<xref rid="R16" ref-type="bibr">16</xref></sup> was obtained from linked GOAL data. Cumulative damage to individual systems was defined by BILD items, as were comorbid heart, cerebrovascular, and pulmonary disease. Current steroid use was self-reported by the participant at the study visit. Body mass index (BMI) was calculated from height and weight; obesity was defined as BMI &#x02265; 30 kg/m<sup>2</sup>. Physical activity was assessed with the International Physical Activity Questionnaire &#x02013; Short Form.<sup><xref rid="R17" ref-type="bibr">17</xref></sup> Depressive symptoms were assessed via the validated 8-item PROMIS Depression Short Form-8a (T-scores; mean=50, SD=10).<sup><xref rid="R18" ref-type="bibr">18</xref>,<xref rid="R19" ref-type="bibr">19</xref></sup> Finally, perceived stress was assessed using the 10-item Perceived Stress Scale (PSS-10) (range 0&#x02013;40; higher scores indicate greater perceived stress).<sup><xref rid="R20" ref-type="bibr">20</xref>,<xref rid="R21" ref-type="bibr">21</xref></sup> Other potential indicators of disability included: physical performance [Short Physical Performance Battery (range, 0&#x02013;12; higher scores=better performance)]<sup><xref rid="R22" ref-type="bibr">22</xref>,<xref rid="R23" ref-type="bibr">23</xref></sup>; physical functioning T-score [PROMIS Physical Functioning-Short Form 12a with (mean=50, SD=10; higher scores=better functioning)]<sup><xref rid="R24" ref-type="bibr">24</xref></sup>; composite age-corrected standard fluid cognition score [NIH Toolbox Fluid Cognition Battery (mean=100, SD=15; higher scores=better performance)]<sup><xref rid="R25" ref-type="bibr">25</xref>&#x02013;<xref rid="R28" ref-type="bibr">28</xref></sup>; and community mobility score [UAB Study of Aging Life-Space Assessment (range, 0&#x02013;120; higher scores=greater community mobility)].<sup><xref rid="R29" ref-type="bibr">29</xref></sup></p></sec></sec><sec id="S11"><title>Statistical Analysis</title><p id="P12">Characteristics of participants were described overall, and percentages with limitations in IADLs and BADLs were described overall and by selected participant characteristics. Patterns in limitations were explored using Venn diagrams and UpSet plots. Adjusted ORs (aORs) for associations of any limitation in IADLs or BADLs with selected characteristics were obtained with multivariable logistic regression, adjusting for demographics (age, sex, and race). In sensitivity and additional analyses, we explored: (<italic toggle="yes">i</italic>) associations of IADL and BADL limitations with characteristics, with additional adjustment for socioeconomic indicators (education and income), SLE-related factors (SLAQ and BILD scores), and comorbid conditions (heart, cerebrovascular, and pulmonary disease); (<italic toggle="yes">ii</italic>) associations of IADL and BADL limitations with characteristics among subgroups of those not receiving disability benefits, those who were Black, and those who were White; (<italic toggle="yes">iii</italic>) associations of IADL and BADL limitations with individual disease damage domains; (<italic toggle="yes">iv</italic>) numbers of limitation in IADLs and BADLs, defined as the number of individual tasks in which individuals reported at least some difficulty; (<italic toggle="yes">v</italic>) severe limitations in IADLs and BADLs, defined as reporting a lot of difficulty with or being unable to do at least one of the IADL or BADL tasks, respectively; and (<italic toggle="yes">vi</italic>) limitations in individual IADL and BADL tasks. Complete case analysis was used. All analyses (statistical significance threshold=0.05) were conducted using Stata v. 18.5 (College Station, TX).</p></sec></sec><sec id="S12"><title>Results</title><sec id="S13"><title>Characteristics of Study Participants</title><p id="P13">Study participants (<italic toggle="yes">N</italic>=436) had a mean age of 46.2; 41.3% were &#x02265;50 years old (<xref rid="T2" ref-type="table">Table 2</xref>). Most were female (91.7%), Black (82.8%), and non-Hispanic (94.5%). About one-quarter (23.4%) had a high school degree or less, and 35.2% had an annual household income of less than $20,000. Nearly half (44.9%) reported receiving disability benefits. The median duration of SLE was 14.8 years, with median SLAQ and BILD scores of 11 and 2, respectively. Cumulative SLE damage was most frequently reported for the ocular (30.7%), cardiovascular (24.3%), and peripheral vascular and musculoskeletal (19.7% each) systems. About half (47.5%) were obese, and 73.7% reported low physical activity (<xref rid="T2" ref-type="table">Table 2</xref>).</p></sec><sec id="S14"><title>Reported Limitations in Activities of Daily Living among Individuals with SLE</title><p id="P14">More than half reported at least some limitation in at least one IADL (<italic toggle="yes">n</italic>=245, 56.2%), while 43.8% (<italic toggle="yes">n</italic>=191) reported at least some limitation in at least one BADL. Most individuals (79.4%) were concordant in their limitations: 39.6% reported no limitations in either IADLs or BADLs, and 39.6% reported limitations in both; however, 16.6% had IADL limitations without BADL limitations and 4.2% had BADL limitations without IADL limitations (<xref rid="F1" ref-type="fig">Figure 1</xref>).</p><p id="P15">Overall, 43.8%, 9.4%, 9.6%, and 37.2% had limitations in zero, one, two, or three or more IADL tasks (<xref rid="F2" ref-type="fig">Figure 2</xref>). Among those with any IADL limitations, 16.7%, 17.1%, and 66.2% had limitations in one, two, or three or more tasks. For BADLs, 56.2%, 16.5%, 7.6%, and 19.7% had limitations in zero, one, two, or three or more tasks (<xref rid="F2" ref-type="fig">Figure 2</xref>); for those with any BADL limitation, 37.7%, 17.3%, and 45.0% had limitations in one, two, or three or more tasks. The numbers of IADL and BADL limitations were strongly positively correlated with each other (&#x003c1;=0.74) and strongly negatively correlated with physical functioning (&#x003c1;=&#x02212;0.70 for IADL and &#x003c1;=&#x02212;0.64 for BADL limitations), while correlations of these limitations with physical and cognitive performance, receipt of disability benefits, and community mobility were low to moderate (<xref rid="SD1" ref-type="supplementary-material">Supplementary Table 1</xref>). Severe limitations (a lot of difficulty with or inability to do any of the tasks) in IADLs and BADLs were seen in 16.3% and 7.8%, respectively, and severe limitations in both IADLs and BADLs were seen in 5.3%.</p><p id="P16">The prevalence of ADL limitation varied widely by individual task. Among the IADLs (<xref rid="F3" ref-type="fig">Figure 3A</xref>), limitation prevalence ranged from 2.5% (using the phone) to 50.7% (housekeeping); about one-third each reported limitations in shopping (33.0%) and doing laundry (37.2%). Among the BADLs (<xref rid="F3" ref-type="fig">Figure 3B</xref>), limitation prevalence ranged from 2.8% (feeding) to 26.6% (transferring); about one-quarter each reported limitations in bathing (25.3%), dressing (24.4%), and continence (22.0%). Most with limitations reported some difficulty for each of the tasks (<xref rid="F3" ref-type="fig">Figure 3</xref>). The most common patterns of limitations among those with any IADL limitations were in housekeeping only (11.8%) and in housekeeping, preparing food, shopping, doing laundry, and transportation (11.8%) (<xref rid="SD1" ref-type="supplementary-material">Supplementary Figure 1A</xref>). The most common patterns of limitations among those with any BADL limitations were in continence only (19.4%) and in bathing, dressing, toileting, and transferring (10.5%) (<xref rid="SD1" ref-type="supplementary-material">Supplementary Figure 1B</xref>).</p></sec><sec id="S15"><title>Factors Associated with Limitations in Activities of Daily Living</title><p id="P17">Prevalence of any IADL limitation was higher in older participants (59.4% vs. 45.4% in those aged &#x02265;50 vs. 18&#x02013;34). After adjustment for sex and race, age &#x02265;50 vs. 18&#x02013;34 years was associated with 78% higher prevalence odds (<xref rid="T3" ref-type="table">Table 3</xref>); this association was consistent with further adjustment but was not statistically significant after adjustment for SLAQ and BILD scores (<xref rid="SD1" ref-type="supplementary-material">Supplementary Table 2</xref>). While IADL limitations were more prevalent in female vs. male (57.3% vs. 44.4%) and Black vs. White (57.6% vs. 47.1%) participants, the differences were not statistically significant (<xref rid="T3" ref-type="table">Table 3</xref>); the associations for Black vs. White race were null after adjustment for education and income (<xref rid="SD1" ref-type="supplementary-material">Supplementary Table 2</xref>). Lower educational attainment was also associated with higher prevalence of IADL limitations, with 2.2- and 1.8-fold higher adjusted prevalence odds for those with high school or less and some college, vs. being a college graduate (<xref rid="T3" ref-type="table">Table 3</xref>), but the associations were attenuated after adjustment for socioeconomic factors (<xref rid="SD1" ref-type="supplementary-material">Supplementary Table 2</xref>). Lower income levels (&#x0003c;$20,000 and $20,000&#x02013;59,999, vs. &#x02265;$60,000) were associated with 3.2- and 2.1-fold higher odds of IADL limitations and were consistent with adjustment. Receipt of disability benefits was associated with 3.5-fold higher odds of limitations in IADLs (<xref rid="T2" ref-type="table">Table 2</xref>); further, of those with any IADL limitations, 58.0% were receiving disability benefits (<xref rid="F1" ref-type="fig">Figure 1</xref>). Higher scores for disease activity (SLAQ; 6.5-fold), depression (3.4-fold), perceived stress (2.7-fold), and disease damage (BILD; 1.8-fold) were all associated with higher odds of IADL limitations (<xref rid="T3" ref-type="table">Table 3</xref>); only higher disease activity and higher depressive symptom scores remained statistically significantly associated with IADL limitations after further adjustment for socioeconomic and SLE-related factors and comorbid conditions (<xref rid="SD1" ref-type="supplementary-material">Supplementary Table 2</xref>). High and moderate vs. low physical activity were associated with 60% and 79% lower odds of IADL limitations. Current steroid use and obesity were not associated with prevalence of IADL limitations (<xref rid="T3" ref-type="table">Table 3</xref>). While underweight status (&#x0003c;18.5 kg/m<sup>2</sup>) was associated with higher odds of limitations (unadjusted OR=2.05, 95% CI 0.61&#x02013;6.85) in separate analyses, the results were not statistically significant. Subgroup analyses showed that associations were similar in those not receiving disability benefits, with slightly stronger effects for lower income, higher disease activity, and higher perceived stress; there were no notable differences between those who were Black and White, except the association of disease damage with IADL limitations was stronger in the White (aOR=6.79, 95% CI 1.80&#x02013;25.7) vs. Black (1.54, 95% CI 1.00&#x02013;2.37) participants (<italic toggle="yes">P</italic> for interaction=0.04; <xref rid="SD1" ref-type="supplementary-material">Supplementary Table 3</xref>). Neuropsychiatric (3.0-fold), pulmonary (2.2-fold), cardiovascular (1.9-fold), and peripheral vascular (1.9-fold) damage were all associated with higher odds of IADL limitations, while the association of musculoskeletal damage with higher odds of IADL limitations (1.6-fold) was not statistically significant (<xref rid="SD1" ref-type="supplementary-material">Supplementary Table 4</xref>).</p><p id="P18">BADL limitations were less frequently reported, but associations of these limitations with characteristics were similar to those seen with IADL limitations. For example, prevalence of any BADL limitation was higher in older participants (47.8% vs. 31.8% in those aged &#x02265;50 vs. 18&#x02013;34); after adjustment for sex and race, age &#x02265;50 vs. 18&#x02013;34 years was associated with 1.9-fold higher prevalence odds (<xref rid="T3" ref-type="table">Table 3</xref>); this association was consistent with further adjustment (<xref rid="SD1" ref-type="supplementary-material">Supplementary Table 5</xref>). Lower educational attainment and lower income were also associated with higher odds of BADL limitations. Unlike IADLs, White vs. Black race was associated with 51% lower odds of BADL limitations (<xref rid="T3" ref-type="table">Table 3</xref>), but this association was attenuated after adjustment for socioeconomic factors (<xref rid="SD1" ref-type="supplementary-material">Supplementary Table 5</xref>). Receipt of disability benefits was associated with 3.1-fold higher odds of limitations in BADLs (<xref rid="T3" ref-type="table">Table 3</xref>), with 61.4% of those with IADL impairments receiving disability benefits (<xref rid="F1" ref-type="fig">Figure 1</xref>). As with IADL limitations, higher scores for disease activity (7.4-fold), depression (3.0-fold), perceived stress (2.5-fold), and disease damage (1.7-fold) were all associated with higher odds of BADL limitations, while high and moderate vs. low physical activity were associated with 52% and 75% lower odds of BADL limitations (<xref rid="T3" ref-type="table">Table 3</xref>); the associations of oldest vs. youngest age, higher disease activity, higher depressive symptom scores, and high vs. low physical activity all remained statistically significant after full adjustment (<xref rid="SD1" ref-type="supplementary-material">Supplementary Table 5</xref>). Current steroid use and obesity were not associated with prevalence of BADL limitations (<xref rid="T3" ref-type="table">Table 3</xref>), nor was underweight status in separate analyses. Associations were similar among those not receiving disability benefits and between those who were Black vs. White (<xref rid="SD1" ref-type="supplementary-material">Supplementary Table 6</xref>). Neuropsychiatric (2.5-fold), pulmonary (2.4-fold), peripheral vascular (1.9-fold), and musculoskeletal (1.7-fold) damage were all associated with higher prevalence of BADL limitations (<xref rid="SD1" ref-type="supplementary-material">Supplementary Table 4</xref>).</p><p id="P19">The number of tasks in which there were limitations also differed by characteristic (<xref rid="SD1" ref-type="supplementary-material">Supplementary Tables 7</xref> and <xref rid="SD1" ref-type="supplementary-material">8</xref>). Black participants were more likely than White participants to report three or more IADL task limitations (41.3% vs. 19.6%; <xref rid="SD1" ref-type="supplementary-material">Supplementary Table 7</xref>) or three or more BADL task limitations (22.7% vs. 5.9%; <xref rid="SD1" ref-type="supplementary-material">Supplementary Table 8</xref>). Those with high school degrees or less or some college also more likely to report three or more IADL limitations (44.1% and 44.5% vs. 25.9%) or three or more BADL limitations (25.5% and 25.0% vs. 11.2%) than those who graduated college, as were those with lower vs. highest income (52.4% and 33.9% vs. 20.8%; and 28.2% and 19.1% vs. 7.6%, respectively). Those with higher scores for disease activity, disease damage, depression, and perceived stress also had statistically significantly higher prevalence of greater numbers of limitations (<xref rid="SD1" ref-type="supplementary-material">Supplementary Tables 7</xref> and <xref rid="SD1" ref-type="supplementary-material">8</xref>). Severe limitations in IADLs and BADLs, while less frequent than any limitations, followed similar patterns of associations with characteristics (<xref rid="SD1" ref-type="supplementary-material">Supplementary Table 9</xref>).</p><p id="P20">Participant characteristics were also associated with individual IADLs (<xref rid="SD1" ref-type="supplementary-material">Supplementary Table 10</xref>) and BADLs (<xref rid="SD1" ref-type="supplementary-material">Supplementary Table 11</xref>) tasks. For example, older age was associated with higher prevalence of limitations in using the phone, food preparation, housekeeping, doing laundry, and managing finances, while Black vs. white race was associated with higher prevalence of limitations in shopping, food preparation, doing laundry, and transportation (<xref rid="SD1" ref-type="supplementary-material">Supplementary Table 10</xref>). Lower income, higher disease activity, and higher scores for depression and perceived stress were associated with higher prevalence of limitations in most IADL tasks (<xref rid="SD1" ref-type="supplementary-material">Supplementary Table 10</xref>). Except for continence, older age was not associated with a higher prevalence of limitations in individual BADL tasks, while the Black vs. White race was associated with a higher prevalence of limitations in bathing, toileting, and transferring (<xref rid="SD1" ref-type="supplementary-material">Supplementary Table 11</xref>). Higher disease activity and perceived stress were both associated with higher prevalence of limitations in all BADL tasks (<xref rid="SD1" ref-type="supplementary-material">Supplementary Table 11</xref>).</p></sec></sec><sec id="S16"><title>Discussion</title><p id="P21">In this population-based SLE cohort, we found that more than half (56%) and nearly half (44%) reported limitations in independently performing at least one IADL and BADL, respectively. Additionally, limitations in multiple tasks were common: 37% and 66% of those with any limitations in IADLs and BADLs had limitations in three or more of the tasks. Further, while most of the reported limitations might be considered mild or moderate (with participants reporting some difficulty), 16% and 8% reported severe limitations in performing at least one IADL or BADL.</p><p id="P22">While data on the prevalence of IADL and BADL difficulty are sparse in the setting of SLE, we can make indirect comparisons of our estimates to the general adult population. For example, 6% of the 2019 U.S. adult population (18&#x02013;64 years) reported severe limitations in at least one ADL, well below our prevalence of severe limitations (16% and 8% for IADLs and ADLs, respectively); in fact, our estimates were more similar to the prevalence in those aged &#x02265;65&#x02013;74 years (19%).<sup><xref rid="R4" ref-type="bibr">4</xref></sup> Among adults aged &#x02265;60 years in the National Health and Nutrition Examination Survey (NHANES) 2011&#x02013;2018, any IADL limitation (some or more difficulty in managing medications, doing household chores, or food preparation) and any BADL limitation (some or more difficulty eating, dressing, getting in and out of bed, or walking between rooms) were reported by 28% and 21%, respectively<sup><xref rid="R30" ref-type="bibr">30</xref></sup>; in a slightly younger population (2018 Health and Retirement Study participants aged &#x02265;50 years), 17% reported any BADL limitations.<sup><xref rid="R31" ref-type="bibr">31</xref></sup> These estimates, using definitions similar to our primary analyses, all fall well below our estimates of 56% and 44% in our younger population. Further, our prevalence estimates for IADL and BADL limitations were lower than those among middle-aged (50&#x02013;64 years) adults (NHANES 2011&#x02013;2014) with congestive heart failure (58% and 56%) but were comparable to, or higher than, those for stroke (52% and 53%), cardiovascular disease (43% and 40%), chronic obstructive pulmonary disease (40% and 35%), arthritis (37% and 36%), chronic kidney disease (30% and 29%), and cancer (31% and 26%).<sup><xref rid="R32" ref-type="bibr">32</xref></sup> Together, our results suggest that adults with SLE may experience more difficulty with both IADLs and BADLs than similarly aged and older adults and adults with other common chronic diseases.</p><p id="P23">In the setting of aging, we generally consider limitations in IADLs (tasks that foster independent living) to precede limitations in BADLs (tasks for basic self-care). Here, we found that 17% had IADL limitations only and 40% reported limitations in both IADLs and BADLs, suggesting that some individuals with SLE may have lived with unrecognized or unaddressed IADL limitations for some time before the development of BADL limitations. Alternatively, the same underlying issues (<italic toggle="yes">e.g</italic>., profound fatigue) might have led to the simultaneous development of IADL and BADL limitations. Overall, these patterns suggest that the conceptualization of aging-related gradual loss of ability to perform IADLs independently, followed in time by limitations in BADLs, may not apply in the setting of SLE.</p><p id="P24">Certain IADL and BADL tasks were more frequently affected in our population. For IADLs, more than half (51%) reported limitations in doing household chores independently. Other common limitations were also in tasks that require both physical and cognitive labor: laundry (37%), shopping (33%), transportation (28%), and food preparation (28%), and these limitations often clustered together within individuals. Limitations in IADLs that arguably require primarily cognitive labor &#x02014; managing medications (14%) and finances (15%) and using the phone (3%) &#x02014; were less commonly reported. Within the BADLs, reported limitations in transferring (27%), bathing (25%), and dressing (24%) were common, perhaps partially reflecting mobility issues, while limitations in feeding (3%) were rarely reported. Surprisingly, limitations in continence were commonly reported (22%; 23% of women and 13% of men), and the most common pattern of BADL limitations seen in our population was limited continence alone. For comparison, 28% and 14% of women and men aged &#x02265;50 years in NHANES reported some level of either urinary or fecal incontinence.<sup><xref rid="R33" ref-type="bibr">33</xref></sup> Limitations in getting on and off the toilet were less common (12%), suggesting that limitations in continence may be more related to bladder symptoms than functional limitations that interfere with toileting. Further epidemiologic exploration of incontinence in SLE is warranted.</p><p id="P25">While older age was associated with higher prevalence of limitations in IADLs and BADLs in our cohort, as expected, several other factors were strongly associated with these limitations. Higher disease activity was associated with ~7-fold higher odds of both IADL and BADL limitations. Related variables, including scores for depression and perceived stress, were also associated with substantially higher odds of these limitations. Lower educational attainment and income, but not sex or race, were generally statistically significantly associated with higher odds of limitations. However, White vs. Black race was associated with 50% lower odds of BADL limitations only. Higher physical activity was associated with lower odds of limitations, while obesity was not associated with IADL or BADL limitations. Overall, these results suggest that observed limitations in ADLs among those with SLE may be driven by emotional functioning as much as by physical and cognitive functioning. Interestingly, the receipt of disability benefits was associated with higher odds of limitations, as expected, but the overlap of these limitations with receipt of disability benefits was far from complete: 42% and 39% of those with IADL and BADL limitations were not receiving disability benefits, and 23% of those receiving disability benefits had no ADL limitations. Further, associations of characteristics with IADL and BADL limitations among those who were not receiving benefits were similar to those in the overall cohort.</p><p id="P26">Of course, BADLs and IADLs are imperfect measures of limitations. IADLs and BADLs do not measure individuals&#x02019; value for being able to perform the task. The Valued Life Activities (VLA) measure accounts for both the ability to perform an activity and the importance that the respondent places on the activity. Using the VLA, Katz <italic toggle="yes">et al</italic>.<sup><xref rid="R7" ref-type="bibr">7</xref></sup> found that most (91%) of their cohort (&#x0003e;800 individuals) had at least one VLA that was affected by their SLE, and VLA disability was associated with 4-fold higher odds of fair or poor self-rated health.<sup><xref rid="R6" ref-type="bibr">6</xref></sup> Additionally, the measured tasks may differ across individuals. For example, limitations in laundry may be more likely for people who need to go to a laundromat or navigate stairs with laundry. Similarly, limitations in transportation may depend on whether an individual has a car or whether public transportation is available, adequate, and easy to use. Our results showing that income was associated with higher odds of IADL limitations support the potential for increased difficulty of tasks in the setting of fewer resources. Finally, at least one IADL task &#x02014; using the phone &#x02014; may be outdated. This task originally captured the ability to hear the phone ringing and get to the phone in time to answer it, as well as dialing, remembering phone numbers, and standing for long periods while speaking. Now it is likely that limitations in using the phone reflect cognitive issues that make it difficult to navigate complex modern phones or issues with vision.</p><p id="P27">Other potential limitations of our study deserve mention. First, causal inference is limited in this cross-sectional study, and factors associated with limitations cannot be considered definitive risk factors. For example, limitations in ADLs might lead to reductions in income, rather than, or in addition to, low income creating or exacerbating ADL limitations. Second, while our cohort was population-based, it might not represent individuals with SLE in other geographic regions. Further, the participants we recruited into APPEAL may have represented a group with fewer IADL and BADL limitations than the GOAL cohort or even the general SLE population in metropolitan Atlanta, which would suggest we may be underestimating the true prevalence of ADL limitations. Third, although we had data from a large cohort, there was likely a lack of power in certain small subgroups (<italic toggle="yes">e.g</italic>., subgroups of White participants), which limited our ability to examine stratified analyses and interaction terms. Finally, there are other unmeasured individual factors that might be important for IADL and BADL limitations, particularly, fatigue and sleep quality. In this study of patient-reported measures, we also did not have an objective measure of disease activity, such as the SLE disease activity index (SLEDAI-2K).<sup><xref rid="R34" ref-type="bibr">34</xref></sup> While we adjusted for comorbid conditions extracted from the BILD score, these represent only severe and SLE-related damage; thus, there is likely suboptimal capture of comorbidity. Because we did not administer the Stanford Health Assessment Questionnaire Disability Index,<sup><xref rid="R35" ref-type="bibr">35</xref></sup> we cannot compare our results to those obtained with this more clinically used instrument. Information on environmental or household factors might also contribute to individuals&#x02019; experiences of limitations: <italic toggle="yes">e.g</italic>., presence of ramps, wide aisles, and accessible parking, along with availability and affordability of delivery or pick-up services, could support independent shopping; and walk-in access, bars, and/or seats in the shower could support independent bathing.</p><p id="P28">Our results suggest that limitations in both IADLs and BADLs are common in SLE. This burden may match or exceed the burden among older adults and those with other chronic diseases. ADL limitations may be more likely among those who report more SLE activity, depressive symptoms, and perceived stress, in addition to those who are older. Further study on the risk factors and outcomes of ADL limitations, as well as specific barriers and facilitators to performing IADLs and BADLs in the setting of SLE, are warranted. Such research will inform evidence-based strategies for improvement in quality of life and maintenance of independence in the aging SLE population.</p></sec><sec sec-type="supplementary-material" id="SM1"><title>Supplementary Material</title><supplementary-material id="SD1" position="float" content-type="local-data"><label>Supinfo</label><media xlink:href="NIHMS2028525-supplement-Supinfo.pdf" id="d67e593" position="anchor"/></supplementary-material></sec></body><back><ack id="S17"><title>Acknowledgments</title><p id="P29">We thank the participants of the APPEAL study and Jessie Black, Aita Akharume, Meaza Girmay, and Sydnei Simpson for completing study visits.</p><sec id="S18"><title>Funding:</title><p id="P30">Research reported in this publication was supported by the National Institute On Aging of the National Institutes of Health under Award Number R01AG061179 (L.C.P.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The GOAL Cohort is currently supported by Centers for Disease Control and Prevention (CDC) Grant 1U01DP006698 (S.S.L.).</p></sec></ack><ref-list><title>References</title><ref id="R1"><label>1.</label><mixed-citation publication-type="journal"><name><surname>Fors Nieves</surname><given-names>CE</given-names></name>, <name><surname>Izmirly</surname><given-names>PM</given-names></name>. <article-title>Mortality in Systemic Lupus Erythematosus: an Updated Review</article-title>. <source>Curr Rheumatol Rep</source>. <year>2016</year>;<volume>18</volume>(<issue>4</issue>):<fpage>21</fpage>.<pub-id pub-id-type="pmid">26984805</pub-id>
</mixed-citation></ref><ref id="R2"><label>2.</label><mixed-citation publication-type="journal"><name><surname>Lawton</surname><given-names>MP</given-names></name>, <name><surname>Brody</surname><given-names>EM</given-names></name>. <article-title>Assessment of older people: self-maintaining and instrumental activities of daily living</article-title>. <source>Gerontologist</source>. <year>1969</year>;<volume>9</volume>(<issue>3</issue>):<fpage>179</fpage>&#x02013;<lpage>86</lpage>.<pub-id pub-id-type="pmid">5349366</pub-id>
</mixed-citation></ref><ref id="R3"><label>3.</label><mixed-citation publication-type="journal"><name><surname>Katz</surname><given-names>S</given-names></name>, <name><surname>Downs</surname><given-names>TD</given-names></name>, <name><surname>Cash</surname><given-names>HR</given-names></name>, <name><surname>Grotz</surname><given-names>RC</given-names></name>. <article-title>Progress in development of the index of ADL</article-title>. <source>Gerontologist</source>. <year>1970</year>;<volume>10</volume>(<issue>1</issue>):<fpage>20</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="pmid">5420677</pub-id>
</mixed-citation></ref><ref id="R4"><label>4.</label><mixed-citation publication-type="book"><collab>National Center for Health Statistics</collab>. <source>Health, United States, 2020&#x02013;2021</source>. <year>2021</year>: <publisher-name>Centers for Disease Control and Prevention</publisher-name>, <publisher-loc>Atlanta, GA</publisher-loc>. <comment>Last updated 1/16/24; Accessed</comment>
<date-in-citation>5/3/2024</date-in-citation>. <comment>Available from: <ext-link xlink:href="https://www.cdc.gov/nchs/hus/" ext-link-type="uri">https://www.cdc.gov/nchs/hus/</ext-link></comment></mixed-citation></ref><ref id="R5"><label>5.</label><mixed-citation publication-type="journal"><name><surname>Theis</surname><given-names>KA</given-names></name>, <name><surname>Murphy</surname><given-names>LB</given-names></name>, <name><surname>Guglielmo</surname><given-names>D</given-names></name>, <etal/>
<article-title>Prevalence of Arthritis and Arthritis-Attributable Activity Limitation &#x02014; United States, 2016&#x02013;2018</article-title>. <source>MMWR Morb Mortal Wkly Rep</source>. <year>2021</year>;<volume>70</volume>:<fpage>1401</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">34618800</pub-id>
</mixed-citation></ref><ref id="R6"><label>6.</label><mixed-citation publication-type="journal"><name><surname>Katz</surname><given-names>P</given-names></name>, <name><surname>Morris</surname><given-names>A</given-names></name>, <name><surname>Gregorich</surname><given-names>S</given-names></name>, <name><surname>Yazdany</surname><given-names>J</given-names></name>, <name><surname>Eisner</surname><given-names>M</given-names></name>, <name><surname>Yelin</surname><given-names>E</given-names></name>, <name><surname>Blanc</surname><given-names>P</given-names></name>. <article-title>Valued life activity disability played a significant role in self-rated health among adults with chronic health conditions</article-title>. <source>J Clin Epidemiol</source>. <year>2009</year>;<volume>62</volume>(<issue>2</issue>):<fpage>158</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="pmid">18722089</pub-id>
</mixed-citation></ref><ref id="R7"><label>7.</label><mixed-citation publication-type="journal"><name><surname>Katz</surname><given-names>P</given-names></name>, <name><surname>Morris</surname><given-names>A</given-names></name>, <name><surname>Trupin</surname><given-names>L</given-names></name>, <name><surname>Yazdany</surname><given-names>J</given-names></name>, <name><surname>Yelin</surname><given-names>E</given-names></name>. <article-title>Disability in valued life activities among individuals with systemic lupus erythematosus</article-title>. <source>Arthritis Rheum</source>. <year>2008</year>;<volume>59</volume>(<issue>4</issue>):<fpage>465</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="pmid">18383406</pub-id>
</mixed-citation></ref><ref id="R8"><label>8.</label><mixed-citation publication-type="journal"><name><surname>Hochberg</surname><given-names>MC</given-names></name>. <article-title>Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus</article-title>. <source>Arthritis Rheum</source>. <year>1997</year>;<volume>40</volume>(<issue>9</issue>):<fpage>1725</fpage>.</mixed-citation></ref><ref id="R9"><label>9.</label><mixed-citation publication-type="journal"><name><surname>Drenkard</surname><given-names>C</given-names></name>, <name><surname>Rask</surname><given-names>KJ</given-names></name>, <name><surname>Easley</surname><given-names>KA</given-names></name>, <name><surname>Bao</surname><given-names>G</given-names></name>, <name><surname>Lim</surname><given-names>SS</given-names></name>. <article-title>Primary preventive services in patients with systemic lupus erythematosus: study from a population-based sample in Southeast U.S</article-title>. <source>Semin Arthritis Rheum</source>. <year>2013</year>;<volume>43</volume>(<issue>2</issue>):<fpage>209</fpage>&#x02013;<lpage>16</lpage>.<pub-id pub-id-type="pmid">23731530</pub-id>
</mixed-citation></ref><ref id="R10"><label>10.</label><mixed-citation publication-type="journal"><name><surname>Lim</surname><given-names>SS</given-names></name>, <name><surname>Drenkard</surname><given-names>C</given-names></name>. <article-title>Understanding Lupus Disparities Through a Social Determinants of Health Framework: The Georgians Organized Against Lupus Research Cohort</article-title>. <source>Rheum Dis Clin North Am</source>. <year>2020</year>;<volume>46</volume>(<issue>4</issue>):<fpage>613</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="pmid">32981639</pub-id>
</mixed-citation></ref><ref id="R11"><label>11.</label><mixed-citation publication-type="journal"><name><surname>Reilly</surname><given-names>MC</given-names></name>, <name><surname>Zbrozek</surname><given-names>AS</given-names></name>, <name><surname>Dukes</surname><given-names>EM</given-names></name>. <article-title>The validity and reproducibility of a work productivity and activity impairment instrument</article-title>. <source>Pharmacoeconomics</source>. <year>1993</year>;<volume>4</volume>(<issue>5</issue>):<fpage>353</fpage>&#x02013;<lpage>65</lpage>.<pub-id pub-id-type="pmid">10146874</pub-id>
</mixed-citation></ref><ref id="R12"><label>12.</label><mixed-citation publication-type="journal"><name><surname>Tang</surname><given-names>K</given-names></name>, <name><surname>Beaton</surname><given-names>DE</given-names></name>, <name><surname>Boonen</surname><given-names>A</given-names></name>, <name><surname>Gignac</surname><given-names>MA</given-names></name>, <name><surname>Bombardier</surname><given-names>C</given-names></name>. <article-title>Measures of work disability and productivity: Rheumatoid Arthritis Specific Work Productivity Survey (WPS-RA), Workplace Activity Limitations Scale (WALS), Work Instability Scale for Rheumatoid Arthritis (RA-WIS), Work Limitations Questionnaire (WLQ), and Work Productivity and Activity Impairment Questionnaire (WPAI)</article-title>. <source>Arthritis Care Res (Hoboken)</source>. <year>2011</year>;<volume>63</volume>
<issue>Suppl 11</issue>:<fpage>S337</fpage>&#x02013;<lpage>49</lpage>.<pub-id pub-id-type="pmid">22588755</pub-id>
</mixed-citation></ref><ref id="R13"><label>13.</label><mixed-citation publication-type="journal"><name><surname>Gordon</surname><given-names>C</given-names></name>, <name><surname>Isenberg</surname><given-names>D</given-names></name>, <name><surname>Lerstrom</surname><given-names>K</given-names></name>, <name><surname>Norton</surname><given-names>Y</given-names></name>, <name><surname>Nikai</surname><given-names>E</given-names></name>, <name><surname>Pushparajah</surname><given-names>DS</given-names></name>, <name><surname>Schneider</surname><given-names>M</given-names></name>. <article-title>The substantial burden of systemic lupus erythematosus on the productivity and careers of patients: a European patient-driven online survey</article-title>. <source>Rheumatology (Oxford)</source>. <year>2013</year>;<volume>52</volume>(<issue>12</issue>):<fpage>2292</fpage>&#x02013;<lpage>301</lpage>.<pub-id pub-id-type="pmid">24049101</pub-id>
</mixed-citation></ref><ref id="R14"><label>14.</label><mixed-citation publication-type="journal"><name><surname>Karlson</surname><given-names>EW</given-names></name>, <name><surname>Daltroy</surname><given-names>LH</given-names></name>, <name><surname>Rivest</surname><given-names>C</given-names></name>, <name><surname>Ramsey-Goldman</surname><given-names>R</given-names></name>, <name><surname>Wright</surname><given-names>EA</given-names></name>, <name><surname>Partridge</surname><given-names>AJ</given-names></name>, <etal/>
<article-title>Validation of a Systemic Lupus Activity Questionnaire (SLAQ) for population studies</article-title>. <source>Lupus</source>. <year>2003</year>;<volume>12</volume>(<issue>4</issue>):<fpage>280</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">12729051</pub-id>
</mixed-citation></ref><ref id="R15"><label>15.</label><mixed-citation publication-type="journal"><name><surname>Yazdany</surname><given-names>J</given-names></name>, <name><surname>Trupin</surname><given-names>L</given-names></name>, <name><surname>Gansky</surname><given-names>SA</given-names></name>, <name><surname>Dall&#x02019;era</surname><given-names>M</given-names></name>, <name><surname>Yelin</surname><given-names>EH</given-names></name>, <name><surname>Criswell</surname><given-names>LA</given-names></name>, <name><surname>Katz</surname><given-names>PP</given-names></name>. <article-title>Brief index of lupus damage: a patient-reported measure of damage in systemic lupus erythematosus</article-title>. <source>Arthritis Care Res (Hoboken)</source>. <year>2011</year>;<volume>63</volume>(<issue>8</issue>):<fpage>1170</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">21584946</pub-id>
</mixed-citation></ref><ref id="R16"><label>16.</label><mixed-citation publication-type="journal"><name><surname>Drenkard</surname><given-names>C</given-names></name>, <name><surname>Yazdany</surname><given-names>J</given-names></name>, <name><surname>Trupin</surname><given-names>L</given-names></name>, <name><surname>Katz</surname><given-names>PP</given-names></name>, <name><surname>Dunlop-Thomas</surname><given-names>C</given-names></name>, <name><surname>Bao</surname><given-names>G</given-names></name>, <name><surname>Lim</surname><given-names>SS</given-names></name>. <article-title>Validity of a self-administered version of the brief index of lupus damage in a predominantly african american systemic lupus erythematosus cohort</article-title>. <source>Arthritis Care Res (Hoboken)</source>. <year>2013</year>.</mixed-citation></ref><ref id="R17"><label>17.</label><mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>PH</given-names></name>, <name><surname>Macfarlane</surname><given-names>DJ</given-names></name>, <name><surname>Lam</surname><given-names>TH</given-names></name>, <name><surname>Stewart</surname><given-names>SM</given-names></name>. <article-title>Validity of the International Physical Activity Questionnaire Short Form (IPAQ-SF): a systematic review</article-title>. <source>Int J Behav Nutr Phys Act</source>. <year>2011</year>;<volume>8</volume>:<fpage>115</fpage>.<pub-id pub-id-type="pmid">22018588</pub-id>
</mixed-citation></ref><ref id="R18"><label>18.</label><mixed-citation publication-type="journal"><name><surname>Teresi</surname><given-names>JA</given-names></name>, <name><surname>Ocepek-Welikson</surname><given-names>K</given-names></name>, <name><surname>Kleinman</surname><given-names>M</given-names></name>, <name><surname>Ramirez</surname><given-names>M</given-names></name>, <name><surname>Kim</surname><given-names>G</given-names></name>. <article-title>Psychometric Properties and Performance of the Patient Reported Outcomes Measurement Information System(<sup>&#x000ae;</sup>) (PROMIS(<sup>&#x000ae;</sup>)) Depression Short Forms in Ethnically Diverse Groups</article-title>. <source>Psychol Test Assess Model</source>. <year>2016</year>;<volume>58</volume>(<issue>1</issue>):<fpage>141</fpage>&#x02013;<lpage>81</lpage>.<pub-id pub-id-type="pmid">28553573</pub-id>
</mixed-citation></ref><ref id="R19"><label>19.</label><mixed-citation publication-type="journal"><name><surname>Hitchon</surname><given-names>CA</given-names></name>, <name><surname>Zhang</surname><given-names>L</given-names></name>, <name><surname>Peschken</surname><given-names>CA</given-names></name>, <name><surname>Lix</surname><given-names>LM</given-names></name>, <name><surname>Graff</surname><given-names>LA</given-names></name>, <name><surname>Fisk</surname><given-names>JD</given-names></name>, <etal/>
<article-title>The validity and reliability of screening measures for depression and anxiety disorders in rheumatoid arthritis</article-title>. <source>Arthritis Care Res (Hoboken)</source>. <year>2019</year>.</mixed-citation></ref><ref id="R20"><label>20.</label><mixed-citation publication-type="journal"><name><surname>Cohen</surname><given-names>S</given-names></name>, <name><surname>Kamarck</surname><given-names>T</given-names></name>, <name><surname>Mermelstein</surname><given-names>R</given-names></name>. <article-title>A global measure of perceived stress</article-title>. <source>J Health Soc Behav</source>. <year>1983</year>;<volume>24</volume>(<issue>4</issue>):<fpage>385</fpage>&#x02013;<lpage>96</lpage>.<pub-id pub-id-type="pmid">6668417</pub-id>
</mixed-citation></ref><ref id="R21"><label>21.</label><mixed-citation publication-type="journal"><name><surname>Ezzati</surname><given-names>A</given-names></name>, <name><surname>Jiang</surname><given-names>J</given-names></name>, <name><surname>Katz</surname><given-names>MJ</given-names></name>, <name><surname>Sliwinski</surname><given-names>MJ</given-names></name>, <name><surname>Zimmerman</surname><given-names>ME</given-names></name>, <name><surname>Lipton</surname><given-names>RB</given-names></name>. <article-title>Validation of the Perceived Stress Scale in a community sample of older adults</article-title>. <source>Int J Geriatr Psychiatry</source>. <year>2014</year>;<volume>29</volume>(<issue>6</issue>):<fpage>645</fpage>&#x02013;<lpage>52</lpage>.<pub-id pub-id-type="pmid">24302253</pub-id>
</mixed-citation></ref><ref id="R22"><label>22.</label><mixed-citation publication-type="journal"><name><surname>Guralnik</surname><given-names>JM</given-names></name>, <name><surname>Simonsick</surname><given-names>EM</given-names></name>, <name><surname>Ferrucci</surname><given-names>L</given-names></name>, <name><surname>Glynn</surname><given-names>RJ</given-names></name>, <name><surname>Berkman</surname><given-names>LF</given-names></name>, <name><surname>Blazer</surname><given-names>DG</given-names></name>, <etal/>
<article-title>A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission</article-title>. <source>J Gerontol</source>. <year>1994</year>;<volume>49</volume>(<issue>2</issue>):<fpage>M85</fpage>&#x02013;<lpage>94</lpage>.<pub-id pub-id-type="pmid">8126356</pub-id>
</mixed-citation></ref><ref id="R23"><label>23.</label><mixed-citation publication-type="journal"><name><surname>Plantinga</surname><given-names>LC</given-names></name>, <name><surname>Bowling</surname><given-names>CB</given-names></name>, <name><surname>Hoge</surname><given-names>C</given-names></name>, <name><surname>Dunlop-Thomas</surname><given-names>C</given-names></name>, <name><surname>Pearce</surname><given-names>BD</given-names></name>, <name><surname>Lim</surname><given-names>SS</given-names></name>, <etal/>
<article-title>Physical Performance in a Diverse, Population-Based Cohort of Individuals With Systemic Lupus Erythematosus</article-title>. <source>Arthritis Care Res (Hoboken)</source>. <year>2024</year>;<volume>76</volume>(<issue>4</issue>):<fpage>517</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="pmid">37885120</pub-id>
</mixed-citation></ref><ref id="R24"><label>24.</label><mixed-citation publication-type="webpage"><collab>Northwestern University</collab>. <source>Introduction to PROMIS</source>. <comment>Available from: <ext-link xlink:href="https://www.healthmeasures.net/explore-measurement-systems/promis/intro-to-promis" ext-link-type="uri">https://www.healthmeasures.net/explore-measurement-systems/promis/intro-to-promis</ext-link>. Last updated 5/16/24.</comment>
<comment>Accessed</comment>
<date-in-citation>4/15/24</date-in-citation>.</mixed-citation></ref><ref id="R25"><label>25.</label><mixed-citation publication-type="webpage"><collab>Toolbox Assessments</collab>. <source>Cognition: NIH Toolbox Cognition Batteries</source>. <comment>Available from: <ext-link xlink:href="https://nihtoolbox.org/domain/cognition/" ext-link-type="uri">https://nihtoolbox.org/domain/cognition/</ext-link>.</comment>
<comment>Accessed</comment>
<date-in-citation>4/15/24</date-in-citation>.</mixed-citation></ref><ref id="R26"><label>26.</label><mixed-citation publication-type="journal"><name><surname>Gershon</surname><given-names>RC</given-names></name>, <name><surname>Cella</surname><given-names>D</given-names></name>, <name><surname>Fox</surname><given-names>NA</given-names></name>, <name><surname>Havlik</surname><given-names>RJ</given-names></name>, <name><surname>Hendrie</surname><given-names>HC</given-names></name>, <name><surname>Wagster</surname><given-names>MV</given-names></name>. <article-title>Assessment of neurological and behavioural function: the NIH Toolbox</article-title>. <source>Lancet Neurol</source>. <year>2010</year>;<volume>9</volume>(<issue>2</issue>):<fpage>138</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">20129161</pub-id>
</mixed-citation></ref><ref id="R27"><label>27.</label><mixed-citation publication-type="journal"><name><surname>Weintraub</surname><given-names>S</given-names></name>, <name><surname>Dikmen</surname><given-names>SS</given-names></name>, <name><surname>Heaton</surname><given-names>RK</given-names></name>, <name><surname>Tulsky</surname><given-names>DS</given-names></name>, <name><surname>Zelazo</surname><given-names>PD</given-names></name>, <name><surname>Slotkin</surname><given-names>J</given-names></name>, <etal/>
<article-title>The cognition battery of the NIH toolbox for assessment of neurological and behavioral function: validation in an adult sample</article-title>. <source>J Int Neuropsychol Soc</source>. <year>2014</year>;<volume>20</volume>(<issue>6</issue>):<fpage>567</fpage>&#x02013;<lpage>78</lpage>.<pub-id pub-id-type="pmid">24959840</pub-id>
</mixed-citation></ref><ref id="R28"><label>28.</label><mixed-citation publication-type="journal"><name><surname>Plantinga</surname><given-names>LC</given-names></name>, <name><surname>Yazdany</surname><given-names>J</given-names></name>, <name><surname>Pearce</surname><given-names>BD</given-names></name>, <name><surname>Hoge</surname><given-names>C</given-names></name>, <name><surname>Dunlop-Thomas</surname><given-names>C</given-names></name>, <name><surname>Lim</surname><given-names>SS</given-names></name>, <etal/>
<article-title>Fluid Cognition among Individuals with Systemic Lupus Erythematosus</article-title>. <source>Arthritis Care Res (Hoboken)</source>. <year>2024</year>;<volume>76</volume>(<issue>8</issue>):<fpage>1121</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="pmid">38528776</pub-id>
</mixed-citation></ref><ref id="R29"><label>29.</label><mixed-citation publication-type="journal"><name><surname>Peel</surname><given-names>C</given-names></name>, <name><surname>Sawyer Baker</surname><given-names>P</given-names></name>, <name><surname>Roth</surname><given-names>DL</given-names></name>, <name><surname>Brown</surname><given-names>CJ</given-names></name>, <name><surname>Brodner</surname><given-names>EV</given-names></name>, <name><surname>Allman</surname><given-names>RM</given-names></name>. <article-title>Assessing mobility in older adults: the UAB Study of Aging Life-Space Assessment</article-title>. <source>Phys Ther</source>. <year>2005</year>;<volume>85</volume>(<issue>10</issue>):<fpage>1008</fpage>&#x02013;<lpage>119</lpage>.<pub-id pub-id-type="pmid">16180950</pub-id>
</mixed-citation></ref><ref id="R30"><label>30.</label><mixed-citation publication-type="journal"><name><surname>Rhee</surname><given-names>TG</given-names></name>, <name><surname>Lee</surname><given-names>K</given-names></name>, <name><surname>Schensul</surname><given-names>JJ</given-names></name>. <article-title>Black-White Disparities in Social and Behavioral Determinants of Health Index and Their Associations with Self-rated Health and Functional Limitations in Older Adults</article-title>. <source>J Gerontol A Biol Sci Med Sci</source>. <year>2021</year>;<volume>76</volume>(<issue>4</issue>):<fpage>735</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="pmid">33049033</pub-id>
</mixed-citation></ref><ref id="R31"><label>31.</label><mixed-citation publication-type="journal"><name><surname>Heimbuch</surname><given-names>H</given-names></name>, <name><surname>Rhee</surname><given-names>Y</given-names></name>, <name><surname>Douglas</surname><given-names>M</given-names></name>, <name><surname>Juhl</surname><given-names>K</given-names></name>, <name><surname>Knoll</surname><given-names>K</given-names></name>, <name><surname>Stastny</surname><given-names>S</given-names></name>, <name><surname>McGrath</surname><given-names>R</given-names></name>. <article-title>Prevalence and Trends of Basic Activities of Daily Living Limitations in Middle-Aged and Older Adults in the United States</article-title>. <source>Epidemiologia (Basel)</source>. <year>2023</year>;<volume>4</volume>(<issue>4</issue>):<fpage>483</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="pmid">37987312</pub-id>
</mixed-citation></ref><ref id="R32"><label>32.</label><mixed-citation publication-type="journal"><name><surname>Bowling</surname><given-names>CB</given-names></name>, <name><surname>Deng</surname><given-names>L</given-names></name>, <name><surname>Sakhuja</surname><given-names>S</given-names></name>, <name><surname>Morey</surname><given-names>MC</given-names></name>, <name><surname>Jaeger</surname><given-names>BC</given-names></name>, <name><surname>Muntner</surname><given-names>P</given-names></name>. <article-title>Prevalence of Activity Limitations and Association with Multimorbidity Among US Adults 50 to 64 Years Old</article-title>. <source>J Gen Intern Med</source>. <year>2019</year>;<volume>34</volume>(<issue>11</issue>):<fpage>2390</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">31435766</pub-id>
</mixed-citation></ref><ref id="R33"><label>33.</label><mixed-citation publication-type="journal"><name><surname>Wu</surname><given-names>JM</given-names></name>, <name><surname>Matthews</surname><given-names>CA</given-names></name>, <name><surname>Vaughan</surname><given-names>CP</given-names></name>, <name><surname>Markland</surname><given-names>AD</given-names></name>. <article-title>Urinary, fecal, and dual incontinence in older U.S. adults</article-title>. <source>J Am Geriatr Soc</source>. <year>2015</year>;<volume>63</volume>(<issue>5</issue>):<fpage>947</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="pmid">25940401</pub-id>
</mixed-citation></ref><ref id="R34"><label>34.</label><mixed-citation publication-type="journal"><name><surname>Gladman</surname><given-names>DD</given-names></name>, <name><surname>Iba&#x000f1;ez</surname><given-names>D</given-names></name>, <name><surname>Urowitz</surname><given-names>MB</given-names></name>. <article-title>Systemic lupus erythematosus disease activity index 2000</article-title>. <source>J Rheumatol</source>. <year>2002</year>;<volume>29</volume>(<issue>2</issue>):<fpage>288</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="pmid">11838846</pub-id>
</mixed-citation></ref><ref id="R35"><label>35.</label><mixed-citation publication-type="journal"><name><surname>Bruce</surname><given-names>B</given-names></name>, <name><surname>Fries</surname><given-names>JF</given-names></name>. <article-title>The Health Assessment Questionnaire (HAQ)</article-title>. <source>Clin Exp Rheumatol</source>. <year>2005</year>;<volume>23</volume>(<issue>5 Suppl 39</issue>):<fpage>S14</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">16273780</pub-id>
</mixed-citation></ref></ref-list></back><floats-group><fig position="float" id="F1"><label>Figure 1.</label><caption><p id="P31">Venn diagram showing overlap of any limitation in instrumental activities of daily living, any limitation in basic activities of daily living, and self-reported receipt of disability benefits among individuals with systemic lupus erythematosus.</p><p id="P32">BADL, basic activity of daily living; IADL, instrumental activity of daily living.</p></caption><graphic xlink:href="nihms-2028525-f0001" position="float"/></fig><fig position="float" id="F2"><label>Figure 2.</label><caption><p id="P33">Distribution of numbers of limitations in instrumental and basic activities of daily living among individuals with systemic lupus erythematosus.</p><p id="P34">BADL, basic activity of daily living; IADL, instrumental activity of daily living.</p></caption><graphic xlink:href="nihms-2028525-f0002" position="float"/></fig><fig position="float" id="F3"><label>Figure 3.</label><caption><p id="P35">Percentage of individuals with SLE with limitations in instrumental (<bold>A</bold>) and basic (<bold>B</bold>) activities of daily living.</p><p id="P36">Stacked bars, percentages within each level of difficulty (some difficulty, a lot of difficulty, and cannot do); overall percentages with any difficulty are shown above the stacked bars. BADL, basic activity of daily living; IADL, instrumental activity of daily living.</p></caption><graphic xlink:href="nihms-2028525-f0003" position="float"/></fig><table-wrap position="float" id="T1"><label>Table 1.</label><caption><p id="P37">Study assessment of basic and instrumental activities of daily living</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Domain/measure</th><th align="left" valign="top" rowspan="1" colspan="1">Wording of item</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Overall question:</td><td align="left" valign="top" rowspan="1" colspan="1">How much difficulty do you have doing the following activities on your own?</td></tr><tr><td rowspan="6" align="left" valign="top" colspan="1">
<underline>Possible responses:</underline>
</td><td align="left" valign="top" rowspan="1" colspan="1">No difficulty</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Some difficulty</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">A lot of difficulty</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Unable to do</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Could do it, but don&#x02019;t<sup><xref rid="TFN2" ref-type="table-fn">a</xref></sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Don&#x02019;t know or refuse<sup><xref rid="TFN3" ref-type="table-fn">b</xref></sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<underline>IADLs</underline>
</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Phone</td><td align="left" valign="top" rowspan="1" colspan="1">Using the phone</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Shopping</td><td align="left" valign="top" rowspan="1" colspan="1">Shopping</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Food</td><td align="left" valign="top" rowspan="1" colspan="1">Preparing food</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Housekeeping</td><td align="left" valign="top" rowspan="1" colspan="1">Housekeeping</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Laundry</td><td align="left" valign="top" rowspan="1" colspan="1">Laundry</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Transportation</td><td align="left" valign="top" rowspan="1" colspan="1">Traveling (car, taxi, public transportation)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Medications</td><td align="left" valign="top" rowspan="1" colspan="1">Managing your medications</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Finances</td><td align="left" valign="top" rowspan="1" colspan="1">Managing your finances</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<underline>BADLs</underline>
</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Bathing</td><td align="left" valign="top" rowspan="1" colspan="1">Bathing or showering</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Dressing</td><td align="left" valign="top" rowspan="1" colspan="1">Getting dressed</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Toileting</td><td align="left" valign="top" rowspan="1" colspan="1">Using the toilet</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Transferring</td><td align="left" valign="top" rowspan="1" colspan="1">Moving in and out of bed and chairs</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Feeding</td><td align="left" valign="top" rowspan="1" colspan="1">Feeding yourself</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Continence</td><td align="left" valign="top" rowspan="1" colspan="1">Controlling your bowel and/or bladder</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p id="P38">BADL, basic activity of daily living; IADL, instrumental activity of daily living.</p></fn><fn id="TFN2"><label>a</label><p id="P39">Treated as &#x0201c;no difficulty.&#x0201d;</p></fn><fn id="TFN3"><label>b</label><p id="P40">Treated as missing.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T2"><label>Table 2.</label><caption><p id="P41">Selected characteristics of study participants with systemic lupus erythematosus</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Characteristic</th><th align="center" valign="top" rowspan="1" colspan="1">Value</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">
<underline>Sociodemographic</underline>
</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mean (SD) age in years</td><td align="center" valign="top" rowspan="1" colspan="1">46.2 (11.8)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Age category, <italic toggle="yes">n</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;18&#x02013;34</td><td align="center" valign="top" rowspan="1" colspan="1">88 (20.2%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;35&#x02013;49</td><td align="center" valign="top" rowspan="1" colspan="1">168 (38.5%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;&#x02265;50</td><td align="center" valign="top" rowspan="1" colspan="1">180 (41.3%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sex,<sup><xref rid="TFN6" ref-type="table-fn">a</xref></sup>
<italic toggle="yes">n</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Female</td><td align="center" valign="top" rowspan="1" colspan="1">400 (91.7%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Male</td><td align="center" valign="top" rowspan="1" colspan="1">36 (8.3%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Race, <italic toggle="yes">n</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Black</td><td align="center" valign="top" rowspan="1" colspan="1">361 (82.8%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Other</td><td align="center" valign="top" rowspan="1" colspan="1">51 (11.7%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;White</td><td align="center" valign="top" rowspan="1" colspan="1">24 (5.5%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hispanic ethnicity, <italic toggle="yes">n</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Hispanic</td><td align="center" valign="top" rowspan="1" colspan="1">24 (5.5%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Not Hispanic</td><td align="center" valign="top" rowspan="1" colspan="1">411 (94.5%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Level of education completed, <italic toggle="yes">n</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;High school degree or less</td><td align="center" valign="top" rowspan="1" colspan="1">102 (23.4%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Some college/associates degree</td><td align="center" valign="top" rowspan="1" colspan="1">164 (37.6%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;College graduate or higher</td><td align="center" valign="top" rowspan="1" colspan="1">170 (39.0%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Currently working, <italic toggle="yes">n</italic> (%)<sup><xref rid="TFN7" ref-type="table-fn">b</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;No</td><td align="center" valign="top" rowspan="1" colspan="1">221 (52.1%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Yes</td><td align="center" valign="top" rowspan="1" colspan="1">203 (47.9%)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Annual household income, <italic toggle="yes">n</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;&#x0003c;$20,000</td><td align="center" valign="top" rowspan="1" colspan="1">149 (35.2%)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;$20,000&#x02013;59,999</td><td align="center" valign="top" rowspan="1" colspan="1">168 (74.9%)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;&#x02265;60,000</td><td align="center" valign="top" rowspan="1" colspan="1">106 (25.1%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Receiving disability benefits,<sup><xref rid="TFN8" ref-type="table-fn">c</xref></sup>
<italic toggle="yes">n</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Yes</td><td align="center" valign="top" rowspan="1" colspan="1">194 (44.9%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;No</td><td align="center" valign="top" rowspan="1" colspan="1">238 (55.1%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<underline>Clinical</underline>
</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Median (IQR) disease duration, years</td><td align="center" valign="top" rowspan="1" colspan="1">14.8 (9.2&#x02013;22.3)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Median (IQR) SLAQ score</td><td align="center" valign="top" rowspan="1" colspan="1">11 (6&#x02013;16)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Median (IQR) BILD score<sup><xref rid="TFN8" ref-type="table-fn">c</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">2 (1&#x02013;4)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cumulative system damage (from BILD<sup><xref rid="TFN8" ref-type="table-fn">c</xref></sup>), <italic toggle="yes">n</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Ocular</td><td align="center" valign="top" rowspan="1" colspan="1">134 (30.7%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Neuropsychiatric</td><td align="center" valign="top" rowspan="1" colspan="1">74 (17.0%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Renal</td><td align="center" valign="top" rowspan="1" colspan="1">37 (8.5%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Pulmonary</td><td align="center" valign="top" rowspan="1" colspan="1">66 (15.1%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Cardiovascular</td><td align="center" valign="top" rowspan="1" colspan="1">106 (24.3%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Peripheral vascular</td><td align="center" valign="top" rowspan="1" colspan="1">73 (19.7%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Gastrointestinal</td><td align="center" valign="top" rowspan="1" colspan="1">103 (23.6%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Musculoskeletal</td><td align="center" valign="top" rowspan="1" colspan="1">86 (19.7%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Dermatologic</td><td align="center" valign="top" rowspan="1" colspan="1">36 (8.3%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Currently taking steroids, <italic toggle="yes">n</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Yes</td><td align="center" valign="top" rowspan="1" colspan="1">185 (42.5%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;No</td><td align="center" valign="top" rowspan="1" colspan="1">250 (57.5%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mean (SD) BMI, kg/m<sup>2</sup></td><td align="center" valign="top" rowspan="1" colspan="1">30.2 (8.2)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Obesity (BMI &#x02265;30 kg/m<sup>2</sup>) <italic toggle="yes">n</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Yes</td><td align="center" valign="top" rowspan="1" colspan="1">202 (47.5%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;No</td><td align="center" valign="top" rowspan="1" colspan="1">223 (52.5%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Physical activity,<sup><xref rid="TFN9" ref-type="table-fn">d</xref></sup>
<italic toggle="yes">n</italic> (%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Low</td><td align="center" valign="top" rowspan="1" colspan="1">317 (73.7%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Moderate</td><td align="center" valign="top" rowspan="1" colspan="1">66 (15.4%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;High</td><td align="center" valign="top" rowspan="1" colspan="1">47 (10.9%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mean (SD) depression T-score<sup><xref rid="TFN10" ref-type="table-fn">e</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">48.2 (9.2)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mean (SD) PSS score<sup><xref rid="TFN11" ref-type="table-fn">f</xref></sup></td><td align="center" valign="top" rowspan="1" colspan="1">15.2 (7.3)</td></tr></tbody></table><table-wrap-foot><fn id="TFN4"><p id="P42">ADL, activity of daily living; BADL, basic ADL; BILD, Brief Index of Lupus Damage (range, 0&#x02013;46; 46 is maximum damage); BMI, body mass index; GOAL, Georgians Organized Against Lupus (parent study); IADL, instrumental ADL; IQR, interquartile (25<sup>th</sup>-75<sup>th</sup> percentile) range; LSA, Life Space Assessment; PSS, Perceived Stress Scale; SLAQ, Systemic Lupus Activity Questionnaire (range, 0&#x02013;47; 47 is maximum activity); SPPB, Short Physical Performance Battery score (range, 0&#x02013;12; higher scores = better performance).</p></fn><fn id="TFN5"><p id="P43">Overall <italic toggle="yes">N</italic>=436, except for: ethnicity (<italic toggle="yes">N</italic>=435), income (<italic toggle="yes">N</italic>=423), disease duration (<italic toggle="yes">N</italic>=435), SLAQ score (<italic toggle="yes">N</italic>=417), BMI (<italic toggle="yes">N</italic>=425), physical activity (<italic toggle="yes">N</italic>=430), depressive symptoms score (<italic toggle="yes">N</italic>=418), perceived stress score (<italic toggle="yes">N</italic>=403), medications (<italic toggle="yes">N</italic>=435), SPPB score (<italic toggle="yes">N</italic>=435), fluid cognition (<italic toggle="yes">N</italic>=197; in-person visits only), self-reported physical functioning (<italic toggle="yes">N</italic>=435), and work status (<italic toggle="yes">N</italic>=424).</p></fn><fn id="TFN6"><label>a</label><p id="P44">Represents sex assigned at birth.</p></fn><fn id="TFN7"><label>b</label><p id="P45">From the Work Productivity and Activity Impairment Questionnaire: General Health v. 2.0.</p></fn><fn id="TFN8"><label>c</label><p id="P46">From the closest GOAL assessment.</p></fn><fn id="TFN9"><label>d</label><p id="P47">From the International Physical Activity Questionnaire &#x02013; Short Form.</p></fn><fn id="TFN10"><label>e</label><p id="P48">From the Patient Reported Outcomes Measurement Information System (PROMIS) Depression Short Form-8a.</p></fn><fn id="TFN11"><label>f</label><p id="P49">From Cohen&#x02019;s 10-item PSS (range, 0&#x02013;40; higher scores representing greater perceived stress).</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T3"><label>Table 3.</label><caption><p id="P50">Any limitations in instrumental and basic activities of daily living among individuals with systemic lupus erythematosus, by selected participant characteristics</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th rowspan="3" align="left" valign="bottom" colspan="1">Characteristic</th><th colspan="4" align="center" valign="top" style="border-bottom: solid 1px" rowspan="1">Any limitation in:</th></tr><tr><th colspan="2" align="center" valign="top" style="border-bottom: solid 1px" rowspan="1">IADLs</th><th colspan="2" align="center" valign="top" style="border-bottom: solid 1px" rowspan="1">BADLs</th></tr><tr><th align="center" valign="top" rowspan="1" colspan="1">No. (%)</th><th align="center" valign="top" rowspan="1" colspan="1">aOR<sup><xref rid="TFN13" ref-type="table-fn">a</xref></sup> (95% CI)</th><th align="center" valign="top" rowspan="1" colspan="1">No. (%)</th><th align="center" valign="top" rowspan="1" colspan="1">aOR<sup><xref rid="TFN13" ref-type="table-fn">a</xref></sup> (95% CI)</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Age category</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;18&#x02013;34</td><td align="center" valign="middle" rowspan="1" colspan="1">40 (45.4%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.00 (ref.)</td><td align="center" valign="middle" rowspan="1" colspan="1">28 (31.8%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.00 (ref.)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;35&#x02013;49</td><td align="center" valign="middle" rowspan="1" colspan="1">98 (58.3%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.65 (0.98&#x02013;2.79)</td><td align="center" valign="middle" rowspan="1" colspan="1">77 (45.8%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.74 (1.01&#x02013;3.02)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;&#x02265;50</td><td align="center" valign="middle" rowspan="1" colspan="1">107 (59.4%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.78 (1.06&#x02013;2.99)</td><td align="center" valign="middle" rowspan="1" colspan="1">86 (47.8%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.94 (1.13&#x02013;3.34)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">P</italic>
<sup>
<xref rid="TFN14" ref-type="table-fn">b</xref>
</sup>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;<italic toggle="yes">0.001</italic></td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">0.04</italic>
</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Sex</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Female</td><td align="center" valign="middle" rowspan="1" colspan="1">229 (57.3%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.00 (ref.)</td><td align="center" valign="middle" rowspan="1" colspan="1">180 (45.0%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.00 (ref.)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Male</td><td align="center" valign="middle" rowspan="1" colspan="1">16 (44.4%)</td><td align="center" valign="top" rowspan="1" colspan="1">0.60 (0.30&#x02013;1.21)</td><td align="center" valign="middle" rowspan="1" colspan="1">11 (30.6%)</td><td align="center" valign="top" rowspan="1" colspan="1">0.53 (0.25&#x02013;1.11)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">P</italic>
<sup>
<xref rid="TFN14" ref-type="table-fn">b</xref>
</sup>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">0.1</italic>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">0.1</italic>
</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Race</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Black</td><td align="center" valign="middle" rowspan="1" colspan="1">208 (57.6%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.00 (ref.)</td><td align="center" valign="middle" rowspan="1" colspan="1">169 (46.8%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.00 (ref.)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Other</td><td align="center" valign="middle" rowspan="1" colspan="1">13 (54.2%)</td><td align="center" valign="top" rowspan="1" colspan="1">0.92 (0.40&#x02013;2.12)</td><td align="center" valign="middle" rowspan="1" colspan="1">6 (25.0%)</td><td align="center" valign="top" rowspan="1" colspan="1">0.40 (0.15&#x02013;1.04)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;White</td><td align="center" valign="middle" rowspan="1" colspan="1">24 (47.1%)</td><td align="center" valign="top" rowspan="1" colspan="1">0.63 (0.35&#x02013;1.14)</td><td align="center" valign="middle" rowspan="1" colspan="1">16 (31.4%)</td><td align="center" valign="top" rowspan="1" colspan="1">0.49 (0.26&#x02013;0.93)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">P</italic>
<sup>
<xref rid="TFN14" ref-type="table-fn">b</xref>
</sup>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">0.4</italic>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">0.02</italic>
</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Hispanic ethnicity</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Hispanic</td><td align="center" valign="middle" rowspan="1" colspan="1">12 (50.0%)</td><td align="center" valign="top" rowspan="1" colspan="1">0.94 (0.38&#x02013;2.33)</td><td align="center" valign="middle" rowspan="1" colspan="1">7 (29.2%)</td><td align="center" valign="top" rowspan="1" colspan="1">0.79 (0.29&#x02013;2.12)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Not Hispanic</td><td align="center" valign="middle" rowspan="1" colspan="1">233 (56.7%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.00 (ref.)</td><td align="center" valign="middle" rowspan="1" colspan="1">184 (44.8%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.00 (ref.)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">P</italic>
<sup>
<xref rid="TFN14" ref-type="table-fn">b</xref>
</sup>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">0.5</italic>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">0.1</italic>
</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Level of education</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;&#x02264;High school</td><td align="center" valign="middle" rowspan="1" colspan="1">66 (64.7%)</td><td align="center" valign="top" rowspan="1" colspan="1">2.20 (1.31&#x02013;3.71)</td><td align="center" valign="middle" rowspan="1" colspan="1">50 (49.0%)</td><td align="center" valign="top" rowspan="1" colspan="1">2.11 (1.25&#x02013;3.55)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Some college</td><td align="center" valign="middle" rowspan="1" colspan="1">101 (61.6%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.88 (1.21&#x02013;2.93)</td><td align="center" valign="middle" rowspan="1" colspan="1">88 (53.7%)</td><td align="center" valign="top" rowspan="1" colspan="1">2.51 (1.59&#x02013;3.97)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;&#x02265;College graduate</td><td align="center" valign="middle" rowspan="1" colspan="1">78 (45.9%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.00 (ref.)</td><td align="center" valign="middle" rowspan="1" colspan="1">53 (31.2%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.00 (ref.)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">P</italic>
<sup>
<xref rid="TFN14" ref-type="table-fn">b</xref>
</sup>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">0.002</italic>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;<italic toggle="yes">0.001</italic></td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td colspan="2" align="left" valign="middle" rowspan="1">Annual household income</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;&#x0003c;$20,000</td><td align="center" valign="middle" rowspan="1" colspan="1">99 (66.4%)</td><td align="center" valign="top" rowspan="1" colspan="1">3.20 (1.80&#x02013;5.68)</td><td align="center" valign="middle" rowspan="1" colspan="1">80 (53.7%)</td><td align="center" valign="top" rowspan="1" colspan="1">2.88 (1.60&#x02013;5.18)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;$20,000&#x02013;59,999</td><td align="center" valign="middle" rowspan="1" colspan="1">95 (56.6%)</td><td align="center" valign="top" rowspan="1" colspan="1">2.06 (1.19&#x02013;3.57)</td><td align="center" valign="middle" rowspan="1" colspan="1">77 (45.8%)</td><td align="center" valign="top" rowspan="1" colspan="1">2.09 (1.18&#x02013;3.70)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;&#x02265;60,000</td><td align="center" valign="middle" rowspan="1" colspan="1">43 (40.6%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.00 (ref.)</td><td align="center" valign="middle" rowspan="1" colspan="1">30 (28.3%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.00 (ref.)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">P</italic>
<sup>
<xref rid="TFN14" ref-type="table-fn">b</xref>
</sup>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;<italic toggle="yes">0.001</italic></td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;<italic toggle="yes">0.001</italic></td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td colspan="2" align="left" valign="middle" rowspan="1">Receiving disability benefits</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Yes</td><td align="center" valign="middle" rowspan="1" colspan="1">141 (72.7%)</td><td align="center" valign="top" rowspan="1" colspan="1">3.53 (2.31&#x02013;5.39)</td><td align="center" valign="middle" rowspan="1" colspan="1">116 (59.8%)</td><td align="center" valign="top" rowspan="1" colspan="1">3.10 (2.05&#x02013;4.69)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;No</td><td align="center" valign="middle" rowspan="1" colspan="1">102 (42.9%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.00 (ref.)</td><td align="center" valign="middle" rowspan="1" colspan="1">73 (30.7%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.00 (ref.)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">P</italic>
<sup>
<xref rid="TFN14" ref-type="table-fn">b</xref>
</sup>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;<italic toggle="yes">0.001</italic></td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;<italic toggle="yes">0.001</italic></td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">SLAQ score</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;&#x02265;Median</td><td align="center" valign="middle" rowspan="1" colspan="1">149 (79.3%)</td><td align="center" valign="top" rowspan="1" colspan="1">6.49 (4.15&#x02013;10.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">130 (69.2%)</td><td align="center" valign="top" rowspan="1" colspan="1">7.35 (4.70&#x02013;11.5)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;&#x0003c;Median</td><td align="center" valign="middle" rowspan="1" colspan="1">85 (37.1%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.00 (ref.)</td><td align="center" valign="middle" rowspan="1" colspan="1">53 (23.1%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.00 (ref.)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">P</italic>
<sup>
<xref rid="TFN14" ref-type="table-fn">b</xref>
</sup>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;<italic toggle="yes">0.001</italic></td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;<italic toggle="yes">0.001</italic></td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">BILD score</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;&#x02265;Median</td><td align="center" valign="middle" rowspan="1" colspan="1">107 (65.2%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.76 (1.17&#x02013;2.66)</td><td align="center" valign="middle" rowspan="1" colspan="1">88 (53.7%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.73 (1.16&#x02013;2.60)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;&#x0003c;Median</td><td align="center" valign="middle" rowspan="1" colspan="1">138 (50.7%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.00 (ref.)</td><td align="center" valign="middle" rowspan="1" colspan="1">103 (37.8%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.00 (ref.)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">P</italic>
<sup>
<xref rid="TFN14" ref-type="table-fn">b</xref>
</sup>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">0.003</italic>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">0.001</italic>
</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">On steroids</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Yes</td><td align="center" valign="middle" rowspan="1" colspan="1">110 (59.5%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.39 (0.93&#x02013;2.08)</td><td align="center" valign="middle" rowspan="1" colspan="1">84 (45.4%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.24 (0.83&#x02013;1.86)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;No</td><td align="center" valign="middle" rowspan="1" colspan="1">134 (53.6%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.00 (ref.)</td><td align="center" valign="middle" rowspan="1" colspan="1">106 (42.4%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.00 (ref.)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">P</italic>
<sup>
<xref rid="TFN14" ref-type="table-fn">b</xref>
</sup>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">0.2</italic>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">0.5</italic>
</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Obesity</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Yes</td><td align="center" valign="middle" rowspan="1" colspan="1">120 (59.4%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.17 (0.78&#x02013;1.74)</td><td align="center" valign="middle" rowspan="1" colspan="1">98 (48.5%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.22 (0.82&#x02013;1.83)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;No</td><td align="center" valign="middle" rowspan="1" colspan="1">119 (53.4%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.00 (ref.)</td><td align="center" valign="middle" rowspan="1" colspan="1">88 (39.5%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.00 (ref.)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">P</italic>
<sup>
<xref rid="TFN14" ref-type="table-fn">b</xref>
</sup>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">0.2</italic>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">0.06</italic>
</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Physical activity</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Low</td><td align="center" valign="middle" rowspan="1" colspan="1">204 (64.4%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.00 (ref.)</td><td align="center" valign="middle" rowspan="1" colspan="1">161 (50.8%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.00 (ref.)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Moderate</td><td align="center" valign="middle" rowspan="1" colspan="1">27 (11.1%)</td><td align="center" valign="top" rowspan="1" colspan="1">0.41 (0.23&#x02013;0.71)</td><td align="center" valign="middle" rowspan="1" colspan="1">20 (30.3%)</td><td align="center" valign="top" rowspan="1" colspan="1">0.48 (0.27&#x02013;0.87)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;High</td><td align="center" valign="middle" rowspan="1" colspan="1">13 (5.3%)</td><td align="center" valign="top" rowspan="1" colspan="1">0.21 (0.11&#x02013;0.43)</td><td align="center" valign="middle" rowspan="1" colspan="1">9 (19.2%)</td><td align="center" valign="top" rowspan="1" colspan="1">0.25 (0.12&#x02013;0.54)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">P</italic>
<sup>
<xref rid="TFN14" ref-type="table-fn">b</xref>
</sup>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;<italic toggle="yes">0.001</italic></td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;<italic toggle="yes">0.001</italic></td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Depression T-score</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;&#x02265;Mean</td><td align="center" valign="middle" rowspan="1" colspan="1">154 (69.5%)</td><td align="center" valign="top" rowspan="1" colspan="1">3.41 (2.26&#x02013;5.15)</td><td align="center" valign="middle" rowspan="1" colspan="1">125 (56.1%)</td><td align="center" valign="top" rowspan="1" colspan="1">2.98 (1.97&#x02013;4.51)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;&#x0003c;Mean</td><td align="center" valign="middle" rowspan="1" colspan="1">81 (41.1%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.00 (ref.)</td><td align="center" valign="middle" rowspan="1" colspan="1">61 (31.0%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.00 (ref.)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">P</italic>
<sup>
<xref rid="TFN14" ref-type="table-fn">b</xref>
</sup>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;<italic toggle="yes">0.001</italic></td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;<italic toggle="yes">0.001</italic></td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PSS score</td><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;&#x02265;Mean</td><td align="center" valign="middle" rowspan="1" colspan="1">141 (69.1%)</td><td align="center" valign="top" rowspan="1" colspan="1">2.72 (1.80&#x02013;4.11)</td><td align="center" valign="middle" rowspan="1" colspan="1">115 (56.4%)</td><td align="center" valign="top" rowspan="1" colspan="1">2.47 (1.64&#x02013;3.74)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;&#x0003c;Mean</td><td align="center" valign="middle" rowspan="1" colspan="1">90 (45.2%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.00 (ref.)</td><td align="center" valign="middle" rowspan="1" colspan="1">68 (34.2%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.00 (ref.)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<italic toggle="yes">P</italic>
<sup>
<xref rid="TFN14" ref-type="table-fn">b</xref>
</sup>
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;<italic toggle="yes">0.001</italic></td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003c;<italic toggle="yes">0.001</italic></td><td align="center" valign="top" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="TFN12"><p id="P51">BILD, Brief Index of Lupus Damage; BMI, body mass index; PSS, Perceived Stress Scale; SLAQ, Systemic Lupus Activity Questionnaire. SLAQ median=12 (<italic toggle="yes">n</italic>=188 &#x02265;median/<italic toggle="yes">n</italic>=229 &#x0003c;median); BILD median=3 (<italic toggle="yes">n</italic>=164 &#x02265;median/<italic toggle="yes">n</italic>=272 &#x0003c;median); depression T-score mean=48.2 (<italic toggle="yes">n</italic>=223 &#x02265;mean/<italic toggle="yes">n</italic>=197 &#x0003c;mean); PSS score mean=16 (<italic toggle="yes">n</italic>=204 &#x02265;mean/<italic toggle="yes">n</italic>=199 &#x0003c;mean).</p></fn><fn id="TFN13"><label>a</label><p id="P52">Age-, sex-, and race-adjusted odds ratio.</p></fn><fn id="TFN14"><label>b</label><p id="P53">By &#x003c7;<sup>2</sup> or Fisher&#x02019;s exact test, as appropriate.</p></fn></table-wrap-foot></table-wrap><boxed-text id="BX1" position="float"><caption><title>Significance and Innovations</title></caption><list list-type="bullet" id="L2"><list-item><p id="P54">Maintaining patients&#x02019; independence should be a priority for SLE providers with increasing numbers of SLE patients who are older</p></list-item><list-item><p id="P55">We sought to understand the current state of activity limitations among the aging population with SLE and the factors associated with these limitations by exploring instrumental activities of daily living (IADLs, or tasks to support independent community living) and basic activities of daily living (BADLs, or tasks to support personal care) among a population-based cohort of primarily Black and female individuals with SLE</p></list-item><list-item><p id="P56">We found that IADL and BADL limitations were common (56% and 44% reporting at least some difficulty, respectively) and that these limitations were more likely among those who were older and those who reported higher disease activity, depressive symptoms, and lower income</p></list-item><list-item><p id="P57">Future research to develop and implement targeted interventions to maintain independence among individuals with SLE as they age is warranted</p></list-item></list></boxed-text></floats-group></article>